A detailed history of Russell Investments Group, Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,295 shares of NVAX stock, worth $12,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,295
Holding current value
$12,108
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$3.89 - $20.97 $5,037 - $27,156
1,295 New
1,295 $16,000
Q3 2023

Nov 13, 2023

SELL
$6.81 - $9.74 $43,529 - $62,258
-6,392 Reduced 98.04%
128 $0
Q2 2023

Aug 10, 2023

SELL
$6.67 - $9.52 $3,901 - $5,569
-585 Reduced 8.23%
6,520 $48,000
Q1 2023

May 09, 2023

SELL
$5.76 - $12.48 $20,442 - $44,291
-3,549 Reduced 33.31%
7,105 $49,000
Q4 2022

Feb 08, 2023

BUY
$8.86 - $25.04 $57,767 - $163,260
6,520 Added 157.72%
10,654 $109,000
Q3 2022

Nov 04, 2022

SELL
$18.2 - $76.12 $9,937 - $41,561
-546 Reduced 11.67%
4,134 $75,000
Q2 2022

Jul 29, 2022

SELL
$36.28 - $75.29 $91,860 - $190,634
-2,532 Reduced 35.11%
4,680 $240,000
Q1 2022

May 05, 2022

SELL
$69.73 - $142.9 $792,830 - $1.62 Million
-11,370 Reduced 61.19%
7,212 $529,000
Q4 2021

Jan 21, 2022

SELL
$134.56 - $217.97 $23,144 - $37,490
-172 Reduced 0.92%
18,582 $2.67 Million
Q3 2021

Nov 08, 2021

SELL
$177.8 - $270.58 $1.34 Million - $2.03 Million
-7,513 Reduced 28.6%
18,754 $3.88 Million
Q2 2021

Aug 04, 2021

SELL
$121.0 - $257.67 $2.02 Million - $4.3 Million
-16,682 Reduced 38.84%
26,267 $5.58 Million
Q1 2021

May 10, 2021

BUY
$112.98 - $319.93 $832,549 - $2.36 Million
7,369 Added 20.71%
42,949 $7.78 Million
Q4 2020

Feb 08, 2021

SELL
$78.74 - $139.5 $400,077 - $708,799
-5,081 Reduced 12.5%
35,580 $3.97 Million
Q3 2020

Nov 09, 2020

BUY
$79.44 - $178.51 $2.9 Million - $6.52 Million
36,540 Added 886.68%
40,661 $4.4 Million
Q2 2020

Aug 05, 2020

BUY
$13.86 - $83.61 $57,117 - $344,556
4,121 New
4,121 $343,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.